Pages that link to "Q28574634"

The following pages link to Catechol-o-methyltransferase inhibition improves set-shifting performance and elevates stimulated dopamine release in the rat prefrontal cortex (Q28574634):

Displaying 50 items.

• Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain (Q24534089) ‎ (← links)
• Neurogenetics and pharmacology of learning, motivation, and cognition (Q24602643) ‎ (← links)
• The neuropsychopharmacology of fronto-executive function: monoaminergic modulation (Q24629562) ‎ (← links)
• CNTRICS final task selection: executive control (Q24651882) ‎ (← links)
• Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder (Q24652360) ‎ (← links)
• The neurodevelopmental hypothesis of schizophrenia, revisited (Q24658343) ‎ (← links)
• Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning (Q24674131) ‎ (← links)
• Genetic evidence implicating DARPP-32 in human frontostriatal structure, function, and cognition (Q24681770) ‎ (← links)
• Effect of Pharmacological Interventions on the Fronto-Cingulo-Parietal Cognitive Control Network in Psychiatric Disorders: A Transdiagnostic Systematic Review of fMRI Studies (Q26744718) ‎ (← links)
• Impulsive delayed reward discounting as a genetically-influenced target for drug abuse prevention: a critical evaluation (Q26782950) ‎ (← links)
• The neural and genetic basis of executive function: attention, cognitive flexibility, and response inhibition (Q27013979) ‎ (← links)
• Site-specific role of catechol-O-methyltransferase in dopamine overflow within prefrontal cortex and dorsal striatum (Q28249776) ‎ (← links)
• Intermediate phenotypes and genetic mechanisms of psychiatric disorders (Q28264588) ‎ (← links)
• Improvement of prepulse inhibition and executive function by the COMT inhibitor tolcapone depends on COMT Val158Met polymorphism (Q28282922) ‎ (← links)
• A transposon in Comt generates mRNA variants and causes widespread expression and behavioral differences among mice (Q28475164) ‎ (← links)
• Polymorphisms of serotonin receptor 2A and 2C genes and COMT in relation to obesity and type 2 diabetes (Q28475961) ‎ (← links)
• Modulation of hippocampal dopamine metabolism and hippocampal-dependent cognitive function by catechol-O-methyltransferase inhibition (Q28580165) ‎ (← links)
• Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence (Q29618819) ‎ (← links)
• Assessing the Cognitive Translational Potential of a Mouse Model of the 22q11.2 Microdeletion Syndrome. (Q30374178) ‎ (← links)
• Generation and characterization of humanized mice carrying COMT158 Met/Val alleles (Q30407994) ‎ (← links)
• Both the COMT Val158Met single-nucleotide polymorphism and sex-dependent differences influence response inhibition (Q30409993) ‎ (← links)
• Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models (Q30416883) ‎ (← links)
• Differential Genetic and Epigenetic Regulation of catechol-O-methyltransferase is Associated with Impaired Fear Inhibition in Posttraumatic Stress Disorder. (Q30429540) ‎ (← links)
• Opposite effects of tolcapone on amphetamine-disrupted startle gating in low vs. high COMT-expressing rat strains (Q30439281) ‎ (← links)
• Genetics of emotion (Q30464322) ‎ (← links)
• A B2 SINE insertion in the Comt1 gene (Comt1(B2i)) results in an overexpressing, behavior modifying allele present in classical inbred mouse strains (Q30476995) ‎ (← links)
• Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice (Q30483916) ‎ (← links)
• Schizophrenia from a neural circuitry perspective: advancing toward rational pharmacological therapies (Q30484459) ‎ (← links)
• Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia (Q30489404) ‎ (← links)
• Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia (Q30578267) ‎ (← links)
• Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors (Q31116328) ‎ (← links)
• Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications (Q33281324) ‎ (← links)
• Association between catechol-O-methyltrasferase Val108/158Met genotype and prefrontal hemodynamic response in schizophrenia (Q33441368) ‎ (← links)
• Old dog, new tricks: the attentional set-shifting test as a novel cognitive behavioral task after controlled cortical impact injury (Q33576385) ‎ (← links)
• Theranostic Biomarkers for Schizophrenia (Q33624412) ‎ (← links)
• A Novel Bio-Psychosocial-Behavioral Treatment Model in Schizophrenia. (Q33624417) ‎ (← links)
• Neurobehavioral evidence for changes in dopamine system activity during adolescence (Q33753341) ‎ (← links)
• Reduced susceptibility to confirmation bias in schizophrenia (Q33818756) ‎ (← links)
• Effects of age, genes, and pulse pressure on executive functions in healthy adults (Q33939121) ‎ (← links)
• COMT genotype affects prefrontal white matter pathways in children and adolescents (Q33987396) ‎ (← links)
• Beneficial effects of desipramine on cognitive function of chronically stressed rats are mediated by alpha1-adrenergic receptors in medial prefrontal cortex (Q34020868) ‎ (← links)
• Modeling deficits in attention, inhibition, and flexibility in HAND. (Q34034134) ‎ (← links)
• Effect of tolcapone on brain activity during a variable attentional control task: a double-blind, placebo-controlled, counter-balanced trial in healthy volunteers (Q34055505) ‎ (← links)
• Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women (Q34092978) ‎ (← links)
• Estrogen shapes dopamine-dependent cognitive processes: implications for women's health (Q34176356) ‎ (← links)
• Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum. (Q34197086) ‎ (← links)
• DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls (Q34204584) ‎ (← links)
• The cognitive neuroscience of ageing (Q34309503) ‎ (← links)
• Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence (Q34372215) ‎ (← links)
• The catechol-O-methyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons (Q34498146) ‎ (← links)